Heinz Kohler

Title: Innovations of Inventor Heinz Kohler

Introduction

Heinz Kohler is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 9 patents, his work has had a profound impact on therapeutic applications.

Latest Patents

Among his latest patents, Kohler has developed autophilic antibodies that possess noncovalent, autophilic properties. These antibodies are derived from those conjugated with an autophilic peptide. They have the potential to promote apoptosis of target cells and enhance therapeutic efficacies in treating patients with diseases responsive to antibody therapy. Additionally, he has worked on murine monoclonal anti-idiotype antibody 3H1 sequences for human carcinoembryonic antigen. This invention provides compositions derived from the sequences encoding the variable light and/or variable heavy regions of monoclonal anti-idiotype antibody 3H1, along with methods for utilizing these compositions.

Career Highlights

Kohler has been associated with prominent organizations such as the University of Kentucky Research Foundation and Immpheron, Inc. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Heinz Kohler has collaborated with notable individuals in his field, including Boyd Eugene Haley and Krishnan Rajagopalan. These collaborations have further enriched his research and innovations.

Conclusion

Heinz Kohler's contributions to biotechnology through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence therapeutic strategies and advancements in medical science.